Revelation Biosciences (REVB) Revenue & Revenue Breakdown
Revelation Biosciences Revenue Highlights
Revelation Biosciences Revenue by Period
Revelation Biosciences Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | - |
Revelation Biosciences Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $37.57K | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | - |
Revelation Biosciences Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
SONN | Sonnet BioTherapeutics | $147.81K | - |
VRAX | Virax Biolabs Group | $8.56K | $76.50K |
CYTO | Altamira Therapeutics | - | $52.73K |
PXMD | PaxMedica | - | - |
ZURA | Zura Bio | - | - |
REVB | Revelation Biosciences | - | - |
HILS | Tharimmune | - | - |
PHIO | Phio Pharmaceuticals | - | - |
ZVSA | ZyVersa Therapeutics | - | - |
RNAZ | TransCode Therapeutics | - | - |
QNRX | Quoin Pharmaceuticals | - | - |
KPRX | Kiora Pharmaceuticals | - | $20.00K |
BWV | Onconetix | - | - |
REVB Revenue FAQ
What is Revelation Biosciences’s yearly revenue?
Revelation Biosciences's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. REVB's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is Revelation Biosciences’s quarterly revenue?
Revelation Biosciences's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). REVB's quarterly revenue for Q4 2023 was $37.57K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).
What is Revelation Biosciences’s revenue growth rate?
Revelation Biosciences's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.